Scott H. Kollins

16.3k total citations · 1 hit paper
213 papers, 9.0k citations indexed

About

Scott H. Kollins is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, Scott H. Kollins has authored 213 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Psychiatry and Mental health, 66 papers in Cognitive Neuroscience and 65 papers in Clinical Psychology. Recurrent topics in Scott H. Kollins's work include Attention Deficit Hyperactivity Disorder (147 papers), Child and Adolescent Psychosocial and Emotional Development (52 papers) and Neurotransmitter Receptor Influence on Behavior (23 papers). Scott H. Kollins is often cited by papers focused on Attention Deficit Hyperactivity Disorder (147 papers), Child and Adolescent Psychosocial and Emotional Development (52 papers) and Neurotransmitter Receptor Influence on Behavior (23 papers). Scott H. Kollins collaborates with scholars based in United States, Canada and United Kingdom. Scott H. Kollins's co-authors include F. Joseph McClernon, Bernard F. Fuemmeler, Thomas S. Critchfield, Craig R. Rush, John T. Mitchell, Tim Wigal, Sharon B. Wigal, James M. Swanson, Jessica R. Lunsford‐Avery and Jeffrey H. Newcorn and has published in prestigious journals such as JAMA, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Scott H. Kollins

202 papers receiving 8.6k citations

Hit Papers

A novel digital intervent... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott H. Kollins United States 53 5.5k 3.1k 2.1k 1.4k 1.1k 213 9.0k
Ridha Joober Canada 55 4.9k 0.9× 2.6k 0.8× 2.8k 1.3× 1.1k 0.8× 486 0.4× 402 10.5k
Gerhard Hellemann United States 49 4.0k 0.7× 2.9k 0.9× 2.3k 1.1× 834 0.6× 339 0.3× 193 8.4k
James J. McGough United States 58 6.4k 1.1× 4.1k 1.3× 2.2k 1.1× 840 0.6× 1.1k 1.0× 132 8.3k
Pál Czobor United States 50 7.1k 1.3× 2.7k 0.9× 3.2k 1.5× 979 0.7× 294 0.3× 197 10.5k
David Coghill United Kingdom 54 8.5k 1.5× 4.2k 1.3× 3.3k 1.6× 498 0.4× 1.7k 1.5× 248 11.4k
Josep Antoni Ramos‐Quiroga Spain 41 5.0k 0.9× 3.0k 0.9× 1.5k 0.7× 700 0.5× 612 0.5× 290 7.0k
Helmut Remschmidt Germany 59 3.2k 0.6× 3.0k 1.0× 4.4k 2.2× 727 0.5× 1.6k 1.4× 369 11.4k
Tobias Banaschewski Germany 63 9.5k 1.7× 7.1k 2.2× 4.9k 2.4× 941 0.7× 1.7k 1.5× 413 15.2k
Lenard A. Adler United States 52 12.1k 2.2× 7.2k 2.3× 3.9k 1.9× 1.2k 0.9× 1.7k 1.5× 217 15.2k
Graham K. Murray United Kingdom 48 3.0k 0.5× 2.5k 0.8× 1.3k 0.6× 922 0.7× 285 0.2× 167 7.1k

Countries citing papers authored by Scott H. Kollins

Since Specialization
Citations

This map shows the geographic impact of Scott H. Kollins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott H. Kollins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott H. Kollins more than expected).

Fields of papers citing papers by Scott H. Kollins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott H. Kollins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott H. Kollins. The network helps show where Scott H. Kollins may publish in the future.

Co-authorship network of co-authors of Scott H. Kollins

This figure shows the co-authorship network connecting the top 25 collaborators of Scott H. Kollins. A scholar is included among the top collaborators of Scott H. Kollins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott H. Kollins. Scott H. Kollins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Davis, Naomi, Rachel Aiello, Kimberly L. H. Carpenter, et al.. (2024). Behavioral characteristics of toddlers later identified with an autism diagnosis, ADHD symptoms, or combined autism and ADHD symptoms. Journal of Child Psychology and Psychiatry. 66(2). 214–224.
3.
Patel, Rashmi, Jesisca Tandi, A. John Rush, et al.. (2022). NeuroBlu, an electronic health record (EHR) trusted research environment (TRE) to support mental healthcare analytics with real-world data. BMJ Open. 12(4). e057227–e057227. 19 indexed citations
4.
Childress, Ann, et al.. (2021). Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 31(5). 342–349. 3 indexed citations
5.
Sweitzer, Maggie M., Lauren R. Pacek, Rachel V. Kozink, et al.. (2021). Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers. Psychopharmacology. 238(9). 2429–2438. 3 indexed citations
6.
Weiss, Margaret D., Andrew J. Cutler, Scott H. Kollins, & Graeme Donnelly. (2021). Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension. Journal of Child and Adolescent Psychopharmacology. 31(9). 610–622. 9 indexed citations
7.
Davis, Naomi, et al.. (2018). Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD. PLoS ONE. 13(1). e0189749–e0189749. 68 indexed citations
9.
Wigal, Sharon B., Laurence L. Greenhill, Earl Nordbrock, et al.. (2014). A Randomized Placebo-Controlled Double-Blind Study Evaluating the Time Course of Response to Methylphenidate Hydrochloride Extended-Release Capsules in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 24(10). 562–569. 32 indexed citations
10.
Sallee, Floyd R., Scott H. Kollins, & Timothy Wigal. (2012). Efficacy of Guanfacine Extended Release in the Treatment of Combined and Inattentive Only Subtypes of Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 22(3). 206–214. 20 indexed citations
11.
Kollins, Scott H., Frank A. López, Bradley Vince, et al.. (2011). Psychomotor Functioning and Alertness with Guanfacine Extended Release in Subjects with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 21(2). 111–120. 45 indexed citations
12.
Volkow, Nora D., Gou‐Jen Wang, Jeffrey H. Newcorn, et al.. (2010). Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Molecular Psychiatry. 16(11). 1147–1154. 300 indexed citations
13.
Ghuman, Jaswinder K., Mark A. Riddle, Benedetto Vitiello, et al.. (2007). Comorbidity Moderates Response to Methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 563–579. 59 indexed citations
14.
Abikoff, Howard, Benedetto Vitiello, Mark A. Riddle, et al.. (2007). Methylphenidate Effects on Functional Outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 581–592. 64 indexed citations
15.
Kratochvil, Christopher J., Brigette S. Vaughan, John S. March, et al.. (2007). A Pilot Study of Atomoxetine in Young Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 17(2). 175–186. 36 indexed citations
16.
Murray, Desiree W., Scott H. Kollins, Kristina K. Hardy, et al.. (2007). Parent versus Teacher Ratings of Attention-Deficit/Hyperactivity Disorder Symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 605–619. 88 indexed citations
17.
Hardy, Kristina K., Scott H. Kollins, Desiree W. Murray, et al.. (2007). Factor Structure of Parent- and Teacher-Rated Attention-Deficit/Hyperactivity Disorder Symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 621–633. 42 indexed citations
18.
Vitiello, Benedetto, Howard Abikoff, Shirley Z. Chuang, et al.. (2007). Effectiveness of Methylphenidate in the 10-Month Continuation Phase of the Preschoolers with ADHD Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 593–603. 56 indexed citations
19.
Swanson, James M., Robert K. Moyzis, James J. McGough, et al.. (2007). Effects of Source of DNA on Genotyping Success Rates and Allele Percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 635–645. 10 indexed citations
20.
Fredericks, Emily M. & Scott H. Kollins. (2005). A Pilot Study of Methylphenidate Preference Assessment in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 15(5). 729–741. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026